Squarepoint’s Dynavax Technologies DVAX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-31,416
| Closed | -$483K | – | 4412 |
|
|
2025
Q4 | $483K | Sell |
31,416
-272,891
| -90% | -$3.01M | ﹤0.01% | 3241 |
|
|
2025
Q3 | $3.02M | Sell |
304,307
-131,270
| -30% | -$1.37M | ﹤0.01% | 1774 |
|
|
2025
Q2 | $4.32M | Buy |
435,577
+300,621
| +223% | +$3.17M | ﹤0.01% | 1553 |
|
|
2025
Q1 | $1.75M | Buy |
134,956
+10,149
| +8% | +$134K | ﹤0.01% | 2202 |
|
|
2024
Q4 | $1.59M | Buy |
124,807
+104,325
| +509% | +$1.26M | ﹤0.01% | 2623 |
|
|
2024
Q3 | $228K | Buy |
+20,482
| New | +$226K | ﹤0.01% | 3611 |
|
|
2023
Q2 | – | Sell |
-17,450
| Closed | -$171K | – | 3658 |
|
|
2023
Q1 | $171K | Sell |
17,450
-14,832
| -46% | -$158K | ﹤0.01% | 2855 |
|
|
2022
Q4 | $343K | Sell |
32,282
-111,594
| -78% | -$1.3M | ﹤0.01% | 2497 |
|
|
2022
Q3 | $1.5M | Buy |
143,876
+102,455
| +247% | +$1.33M | 0.01% | 1504 |
|
|
2022
Q2 | $521K | Buy |
41,421
+28,391
| +218% | +$302K | ﹤0.01% | 1994 |
|
|
2022
Q1 | $141K | Sell |
13,030
-29,048
| -69% | -$353K | ﹤0.01% | 2553 |
|
|
2021
Q4 | $592K | Sell |
42,078
-45,980
| -52% | -$757K | ﹤0.01% | 2028 |
|
|
2021
Q3 | $1.69M | Sell |
88,058
-38,467
| -30% | -$511K | ﹤0.01% | 1289 |
|
|
2021
Q2 | $1.25M | Buy |
126,525
+28,656
| +29% | +$261K | ﹤0.01% | 1473 |
|
|
2021
Q1 | $962K | Buy |
+97,869
| New | +$807K | 0.01% | 1536 |
|
|
2020
Q4 | – | Sell |
-357,134
| Closed | -$1.54M | – | 2987 |
|
|
2020
Q3 | $1.54M | Buy |
357,134
+302,115
| +549% | +$2.16M | 0.02% | 772 |
|
|
2020
Q2 | $488K | Sell |
55,019
-132,189
| -71% | -$668K | 0.01% | 1331 |
|
|
2020
Q1 | $661K | Buy |
+187,208
| New | +$868K | 0.02% | 896 |
|
|
2019
Q2 | – | Sell |
-14,716
| Closed | -$108K | – | 2433 |
|
|
2019
Q1 | $108K | Sell |
14,716
-6,223
| -30% | -$60.8K | ﹤0.01% | 2030 |
|
|
2018
Q4 | $192K | Buy |
20,939
+2,982
| +17% | +$33K | ﹤0.01% | 1697 |
|
|
2018
Q3 | $223K | Sell |
17,957
-25,343
| -59% | -$343K | ﹤0.01% | 1714 |
|
|
2018
Q2 | $660K | Buy |
+43,300
| New | +$749K | 0.01% | 1059 |
|
|
2017
Q1 | – | Sell |
-127,899
| Closed | -$505K | – | 1602 |
|
|
2016
Q4 | $505K | Buy |
127,899
+113,448
| +785% | +$831K | 0.02% | 824 |
|
|
2016
Q3 | $152K | Buy |
+14,451
| New | +$208K | 0.01% | 925 |
|
|
2016
Q1 | – | Sell |
-18,800
| Closed | -$454K | – | 1223 |
|
|
2015
Q4 | $454K | Buy |
+18,800
| New | +$471K | 0.05% | 588 |
|
Other funds holding DVAX
Squarepoint's DVAX Position: Q1 2026 in Review
Squarepoint sold out of Dynavax Technologies (DVAX) in Q1 2026, closing a stake of 31,416 shares — an estimated $483K sold.
Squarepoint first reported a position in DVAX in Q4 2015 and held it in 25 quarters. The position peaked at $4.32M in Q2 2025. 1 fund tracked by Wall St. Rank holds DVAX as of Q1 2026.
- Squarepoint reported no remaining Dynavax Technologies position as of Q1 2026 after selling out during the quarter.
- Squarepoint sold 31,416 Dynavax Technologies shares in Q1 2026, an estimated $483K.
- Squarepoint first reported a position in Dynavax Technologies in Q4 2015 and held it in 25 quarters.
- Squarepoint's Dynavax Technologies position peaked at $4.32M in Q2 2025.
- 1 fund tracked by Wall St. Rank held Dynavax Technologies as of Q1 2026.
Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.